EBIT: Income before interest and taxes.
Vera Therapeutics, Inc. (VERA) had EBIT of $-112.49M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-109.47M |
|
-- |
|
-- |
|
$112.49M |
|
$-112.49M |
|
$3.02M |
|
$-109.47M |
|
$-109.47M |
|
$-109.47M |
|
$-109.47M |
|
$-109.47M |
|
$-109.47M |
|
|
EBIT |
$-112.49M |
$-112.81M |
|
71.84M |
|
71.84M |
|
$-1.52 |
|
$-1.52 |
|
| Balance Sheet Financials | |
$527.49M |
|
-- |
|
$5.49M |
|
$532.98M |
|
$48.32M |
|
$75.23M |
|
$76.91M |
|
$125.23M |
|
$407.76M |
|
$407.76M |
|
$407.76M |
|
71.96M |
|
| Cash Flow Statement Financials | |
$-206.75M |
|
$-104.96M |
|
$5.86M |
|
$354.73M |
|
$48.88M |
|
$-305.85M |
|
$29.07M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.92 |
|
-- |
|
-- |
|
0.16 |
|
0.18 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-206.78M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-26.85% |
|
-26.85% |
|
-20.54% |
|
-22.67% |
|
$5.67 |
|
$-2.88 |
|
$-2.88 |
|